Skip to main content
. 2015 Mar 29;6(16):14209–14219. doi: 10.18632/oncotarget.3694

Figure 2.

Figure 2

(A) Positive programmed cell death-ligand 1 (PD-L1) immunohistochemical staining with a membranous pattern. (B) Negative PD-L1 immunohistochemical staining. Original magnification, 20 ×.